Liddle Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The SCNN1G gene, located on human chromosome 16p12, encodes the gamma subunit of the amiloride-sensitive epithelial sodium channel, and mutations in SCNN1G can result in Liddle's syndrome or pseudohypoaldosteronism type I.
|
11463765 |
2001 |
Liddle Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We screened an adolescent with severe hypertension who was clinically diagnosed with Liddle syndrome for mutations in the C-terminus of the SCNN1B and SCNN1G genes.
|
22809657 |
2013 |
Liddle Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The aim of the study was to search for mutations of SCNN1B and SCNN1G in an Italian family with apparently dominant autosomal transmission of a clinical phenotype consistent with Liddle's syndrome.
|
18398334 |
2008 |
Liddle Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Genetic analysis identified a novel SCNN1G frameshift mutation, p.Arg586Valfs*598, in the proband with LS.
|
30977777 |
2019 |
Liddle Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the alpha-, beta- and gamma-ENaC subunit genes (SCNN1A, SCNN1B and SCNN1G) are associated with multi-system pseudohypoaldosteronism (PHA), and mutations in the PY motif of carboxy-terminal region of beta and gamma subunits are associated with Liddle syndrome of hereditary hypertension.
|
20064610 |
2010 |
Liddle Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
To identify mutation in SCNN1B and SCNN1G genes in an adolescent with suspicious Liddle syndrome and his family members and to explore the screening target subjects of Liddle syndrome.
|
28718682 |
2018 |
Liddle Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Genetic diagnosis of Liddle's syndrome by mutation analysis of SCNN1B and SCNN1G in a Chinese family.
|
22613642 |
2012 |
Liddle Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In accord, loss of function mutations in ENaC (PHA1) cause hypotension, whereas gain of function mutations (Liddle syndrome) result in hypertension.
|
18691017 |
2008 |
Liddle Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The sequence of C-terminus of SCNN1B and SCNN1G were screened in the two families with likely Liddle syndrome.
|
24474657 |
2014 |
Liddle Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The purpose of this study was to determine whether mutations of SCNN1B or SCNN1G were present in a patient clinically suspected to have Liddle syndrome with no familial history of hypertension.
|
17634077 |
2007 |
Pseudohypoaldosteronism, Type I
|
0.560 |
GeneticVariation
|
disease |
BEFREE |
Syndromes of aldosterone resistance have been also characterized molecularly and mutations in the gene MLR, encoding mineralocorticoid receptor, and in the genes SNCC1A, SNCC1B, and SCNN1G, encoding subunits of the epithelial Na+ channel, have been found in dominant and recessive forms of pseudohypoaldosteronism type 1, respectively.
|
11045400 |
2000 |
Pseudohypoaldosteronism, Type I
|
0.560 |
GeneticVariation
|
disease |
BEFREE |
The SCNN1G gene, located on human chromosome 16p12, encodes the gamma subunit of the amiloride-sensitive epithelial sodium channel, and mutations in SCNN1G can result in Liddle's syndrome or pseudohypoaldosteronism type I.
|
11463765 |
2001 |
Pseudohypoaldosteronism, Type I
|
0.560 |
GeneticVariation
|
disease |
BEFREE |
Pseudohypoaldosteronism type 1 (PHA1) is a monogenic disease caused by mutations in the genes encoding the human mineralocorticoid receptor (MR) or the α (SCNN1A), β (SCNN1B) or γ (SCNN1G) subunit of the epithelial Na(+) channel (ENaC).
|
23416952 |
2013 |
Pseudohypoaldosteronism, Type I
|
0.560 |
GeneticVariation
|
disease |
BEFREE |
Pseudohypoaldosteronism type 1 (PHA1, OMIM 264350) is a rare Mendelian disorder characterised by end-organ unresponsiveness to mineralocorticoids.
|
8824886 |
1996 |
Pseudohypoaldosteronism, Type I
|
0.560 |
GeneticVariation
|
disease |
BEFREE |
Pseudohypoaldosteronism type 1 (PHA1, OMIM 264350) is an uncommon inherited disorder characterized by salt-wasting and end-organ unresponsiveness to mineralocorticoids.
|
8640238 |
1996 |
Pseudohypoaldosteronism, Type I
|
0.560 |
GeneticVariation
|
disease |
BEFREE |
Pseudohypoaldosteronism type 1 (PHA-1, MIM #264350) is caused by defective transepithelial sodium transport.
|
21750640 |
2011 |
Hypertensive disease
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Liddle's syndrome of hypertension and pseudoaldosteronism has been shown to arise from mutations in SCNN1B and SCNN1G.
|
8824886 |
1996 |
Hypertensive disease
|
0.500 |
GeneticVariation
|
group |
BEFREE |
In accord, loss of function mutations in ENaC (PHA1) cause hypotension, whereas gain of function mutations (Liddle syndrome) result in hypertension.
|
18691017 |
2008 |
Hypertensive disease
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Mutations in the alpha-, beta- and gamma-ENaC subunit genes (SCNN1A, SCNN1B and SCNN1G) are associated with multi-system pseudohypoaldosteronism (PHA), and mutations in the PY motif of carboxy-terminal region of beta and gamma subunits are associated with Liddle syndrome of hereditary hypertension.
|
20064610 |
2010 |
Hypertensive disease
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension.
|
15661075 |
2005 |
Hypertensive disease
|
0.500 |
GeneticVariation
|
group |
BEFREE |
The purpose of this study was to determine whether mutations of SCNN1B or SCNN1G were present in a patient clinically suspected to have Liddle syndrome with no familial history of hypertension.
|
17634077 |
2007 |
Hypertensive disease
|
0.500 |
GeneticVariation
|
group |
BEFREE |
The roles of these missense mutations in the SCNN1B or SCNN1G gene identified in hypertensive patients are not clear in the pathogenesis of hypertension and the regulation of electrolytes.
|
15198480 |
2004 |
Pseudohypoaldosteronism
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the alpha-, beta- and gamma-ENaC subunit genes (SCNN1A, SCNN1B and SCNN1G) are associated with multi-system pseudohypoaldosteronism (PHA), and mutations in the PY motif of carboxy-terminal region of beta and gamma subunits are associated with Liddle syndrome of hereditary hypertension.
|
20064610 |
2010 |
Pseudohypoaldosteronism
|
0.430 |
GeneticVariation
|
disease |
LHGDN |
Novel mutations responsible for autosomal recessive multisystem pseudohypoaldosteronism and sequence variants in epithelial sodium channel alpha-, beta-, and gamma-subunit genes.
|
12107247 |
2002 |
Pseudohypoaldosteronism
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
One girl showed pseudohypoaldosteronism related to mutations of the SCNN1G gene encoding for the epithelial sodium channel.
|
27485500 |
2016 |